Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New insights into the anticancer therapeutic potential of maytansine and its derivatives
Sameen Zafar, Muhammad Armaghan, Khushbukhat Khan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115039-115039
Open Access | Times Cited: 21

Showing 21 citing articles:

Anticancer Potential of the Plant‐Derived Saponin Gracillin: A Comprehensive Review of Mechanistic Approaches
Md. Shimul Bhuia, Raihan Chowdhury, Fatema Akter Sonia, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 9
Closed Access | Times Cited: 34
Maytansinoids in cancer therapy: advancements in antibody–drug conjugates and nanotechnology-enhanced drug delivery systems
Matteo Perra, Ines Castangia, Matteo Aroffu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Advancements in antibody-drug conjugates as cancer therapeutics
Jung Yin Fong, Zhixin Phuna, D. Chong, et al.
Journal of the National Cancer Center (2025)
Open Access | Times Cited: 1
Antibody–Drug Conjugates—Evolution and Perspectives
Adriana Aurelia Chiș, Carmen Maximiliana Dobrea, Anca Maria Arseniu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6969-6969
Open Access | Times Cited: 6
Actinomycetes are a natural resource for sustainable pest control and safeguarding agriculture
Mohamed K. Diab, Hala Mead, Mohamad Khedr, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 6
Closed Access | Times Cited: 6
Natural-source payloads used in the conjugated drugs architecture for cancer therapy: Recent advances and future directions
Cuiping Li, Kourong Shi, Siyuan Zhao, et al.
Pharmacological Research (2024) Vol. 207, pp. 107341-107341
Open Access | Times Cited: 6
An update on the development on tubulin inhibitors for the treatment of solid tumors
Prasanna Anjaneyulu Yakkala, Shaik O. Rahaman, P.S. Lakshmi Soukya, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 3, pp. 193-220
Closed Access | Times Cited: 4
Understanding crucial factors in cultured meat production: A comprehensive SWOT analysis
Farzana Choudhary, S. A. Khandi, Rana Muhammad Aadil, et al.
Applied Food Research (2024) Vol. 4, Iss. 2, pp. 100474-100474
Open Access | Times Cited: 4
Synthesis and Evaluation of Novel Dimethyltriazene Epoxide and 2-Thioxotetrahydropyrimidin-5(2H)-one Derivatives as Potential Anticancer Agents
Vidhya V. Jadvani, Yogesh T. Naliapara
Russian Journal of Organic Chemistry (2025) Vol. 61, Iss. 2, pp. 272-279
Closed Access
Current Role of Topoisomerase I Inhibitors for the Treatment of Mesenchymal Malignancies and Their Potential Future Use as Payload of Sarcoma-Specific Antibody-Drug Conjugates
Patrick Schöffski, Chao‐Chi Wang, Morris Patrick Schöffski, et al.
Oncology Research and Treatment (2023) Vol. 47, Iss. 1-2, pp. 18-41
Open Access | Times Cited: 10
Therapeutic antibodies in oncology: an immunopharmacological overview
Karen Toledo‐Stuardo, Carolina Ribeiro, Fabiola González‐Herrera, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 12
Open Access | Times Cited: 3
ZKSCAN5 activates LAPTM5 expression by recruiting SETD7 to promote metastasis in pancreatic ductal adenocarcinoma.
Yong Yang, Wei Xie, Xuan Qiao, et al.
PubMed (2024) Vol. 39, Iss. 6, pp. 747-760
Closed Access | Times Cited: 2
Isoliquiritigenin attenuates neuroinflammation after subarachnoid hemorrhage through inhibition of NF‐κB‐mediated NLRP3 inflammasome activation
Wenfei Zhang, Xiang Tao, Chen Chen, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 2
Closed Access | Times Cited: 2
The effect of lavender on mood disorders associated with the use of combined oral contraceptives (COCs): a triple-blinded randomized controlled trial
Mina Naghdi, Azizeh Farshbaf-Khalili, Jila Nahaee, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Recent Progress in the Development of Peptide-Drug Conjugates (PDCs) for Cancer Therapy
Haiqi He, Xin Deng, Zhijie Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117204-117204
Closed Access | Times Cited: 2
Fundamental Considerations of Targeted Drug Therapies for Breast Cancer
Ileana Castillo‐Tobías, Lia Berlanga, Joan Poblano, et al.
Future Pharmacology (2023) Vol. 3, Iss. 4, pp. 686-707
Open Access | Times Cited: 5
CD7 Nanobody-Based Immuno-Nanotoxin for Targeted Treatment of T-Cell Acute Lymphoblastic Leukemia
Yangyang Dong, Fengtao You, Yifan Zhang, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 7, pp. 7195-7202
Closed Access | Times Cited: 1
Oestrogen receptor positive breast cancer and its embedded mechanism: breast cancer resistance to conventional drugs and related therapies, a review
Manu Yadav, Ishita Vaishkiar, Ananya Sharma, et al.
Open Biology (2024) Vol. 14, Iss. 6
Open Access | Times Cited: 1
Cardiovascular adverse events in patients with HER2-positive breast cancer treated with trastuzumab-drug conjugates : a Bayesian disproportional real world study for signal detection leveraging the FDA adverse event reporting system (FAERS)
Jinfang Hu, Siyu Chen, Huanhuan Jia, et al.
Expert Opinion on Drug Safety (2024)
Closed Access
Unlocking Natural Potential: Antibody‐Drug Conjugates With Naturally Derived Payloads for Cancer Therapy
Xue Jiang, Wan Najbah Nik Nabil, Yufei Ze, et al.
Phytotherapy Research (2024)
Closed Access
Biological evaluation of 9-thioansamitocin P3
Natalya I. Vasilevich, Huangyu Jiang, Haihua Xiao, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 696, pp. 149483-149483
Closed Access
Page 1

Scroll to top